Engineering cGAS-agonistic oligonucleotides as therapeutics and vaccine adjuvants for cancer immunotherapy
Shurong Zhou(University of Michigan), Guizhi Zhu(University of Michigan), Xiang Liu(Shanghai Jiao Tong University), Bei Zhang(Virginia Commonwealth University), Ting Su(Sun Yat-sen University), Furong Cheng(Cangzhou Central Hospital), Shaheer Alam(Virginia Commonwealth University), Jinze Liu(Virginia Commonwealth University), Janét Cole(Virginia Commonwealth University)
Cited by 4
Related Papers
Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines
|Journal of Controlled Release|2022|344
Hyaluronic Acid-Decorated Graphene Oxide Nanohybrids as Nanocarriers for Targeted and pH-Responsive Anticancer Drug Delivery
|ACS Applied Materials & Interfaces|2014|202
Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
|Advanced Science|2022|73
Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases
|Accounts of Chemical Research|2023|71
Small GTPases: Structure, biological function and its interaction with nanoparticles
|Asian Journal of Pharmaceutical Sciences|2018|70